Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.

Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.

Generate Key Takeaways What are the most common COVID-19 symptoms doctors are seeing in025? Read on to find out what to look ...

As flu season arrives, a new highly infectious COVID-19 variant, Stratus (XFG), is driving a surge in US cases, first ...

Flu season is fast approaching in the northern hemisphere. And a taste-based influenza test could someday have you swapping ...

German scientists have designed a new molecular sensor to release a thyme flavor when it encounters the flu virus.

Molecular Designs, a developer and manufacturer of molecular infectious disease assays, today announced it has submitted a ...

Covid-19 has infected more than 235M people and killed over 4.8M globally. Here are the virus-related developments for October 4: ...

Discover how Singapore Food Agency (SFA) scientists conduct rigorous tests to ensure food items like mooncakes are safe for ...

Flu season is fast approaching in the northern hemisphere. And a taste-based influenza test could someday have you swapping nasal swabs for chewing gum. A new molecular sensor has been designed to ...

“Given India’s success in curbing international outbreaks such as Zika and the Nipah virus infections, Asian countries have ...

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...